Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis
- 148 Downloads
Nonalcoholic fatty liver disease (NAFLD) has emerged as a ubiquitous liver disorder with occasional serious overtones. Although diabetes and obesity were initially held culpable, insulin resistance (IR) is now considered the fundamental operative mechanism. IR is probably the "first step" in nonalcoholic steatohepatitis (NASH). Oxidative stress may be the elusive "second" of possibly multiple steps in the progression of steatosis to fibrosing steatohepatitis. Because hepatic iron promotes oxidative stress, it was mooted as a contributory cofactor in NASH. This proposal was strengthened by an association with hepatic fibrosis. Subsequent studies have shown neither a significant increase in hepatic iron nor an association between hepatic iron and any of the histologic determinants in NASH. Likewise, the increased prevalence of hemochromatosis gene (HFE) mutations in some studies appears to be largely irrelevant to the development of hepatic fibrosis. Excess hepatic iron may occur in insulin resistance-associated iron overload (IRHIO), characterized by hyperferritinemia with normal to mild increases in transferrin saturation. Although patients with IRHIO have a high prevalence of IR-related metabolic disorders, the relationship of IRHIO to NASH is unclear. A recent study showed improvement in insulin sensitivity with the use of venesection in patients with NAFLD, but this approach cannot be implemented without extensive review.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 28.Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al.: Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001, 120:1183–1192. Patients with NASH and fatty liver are less sensitive to insulin than are control subjects. The site of insulin resistance is probably peripheral, not hepatic.PubMedCrossRefGoogle Scholar
- 32.Chitturi S, Abeygunasekera S, Farrell GC, et al.: NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002, 35:373–379. This study found a specific association of NASH (compared with hepatitis C) with insulin resistance and a high prevalence of features of insulin resistance.PubMedCrossRefGoogle Scholar
- 37.Chitturi S, Weltman M, Farrell GC, et al.: HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology 2002, 36:142–149. The latest in the series of studies examining the association between hepatic iron, HFE, and NASH. The hypothesis that excess hepatic iron is present in NASH and is a determinant of hepatic fibrosis is dispelled in this report.PubMedCrossRefGoogle Scholar
- 39.George DK, Goldwurm S, MacDonald GA, et al.: Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998, 114:311–318. The first study that raised the prospect of excess hepatic iron contributing to hepatic fibrosis in NASH.PubMedCrossRefGoogle Scholar
- 43.Moirand R, Mortaji AM, Lor’eal L, et al.: A new syndrome of iron overload with normal transferrin saturation. Lancet 1997, 349:95–97. The first of a series of studies showing an association between hepatic iron overload and insulin resistance. Subsequent studies have expanded this entity and have led to suggestions that venesection may be beneficial in its management.PubMedCrossRefGoogle Scholar
- 47.Facchini FS, Hua NW, Stoohs RA: Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology 2002, 122:931–939. This provocative study suggests that iron depletion improves insulin sensitivity in NAFLD.PubMedCrossRefGoogle Scholar